Opportunity Information: Apply for PA 17 084
The Eradication of HIV-1 from Central Nervous System Reservoirs (R01) opportunity (Funding Opportunity Number PA-17-084) is a National Institutes of Health (NIH) discretionary grant solicitation aimed at advancing research on why HIV-1 persists in the central nervous system (CNS) even when a person is on effective antiretroviral therapy and has viral suppression in the blood. The central purpose is to support studies that clarify the biological mechanisms that allow HIV-1 to remain in the CNS and to develop, test, or refine strategies that could ultimately eliminate (eradicate) these CNS reservoirs or otherwise neutralize their clinical impact. The FOA emphasizes that work can be both basic and translational, meaning it can range from fundamental lab-based discovery (such as identifying cell types and pathways involved in persistence) to research that moves toward practical interventions, biomarkers, or therapeutic approaches relevant to patient care.
A key feature of the announcement is its specific focus on the CNS context of viral suppression. In practical terms, the FOA is concerned with HIV-1 persistence that remains despite treatment success as typically measured in peripheral blood. This focus recognizes that the CNS has unique biology, immune environment, and drug penetration constraints that can create sanctuary-like conditions for HIV-1. The announcement therefore encourages research that investigates how HIV behaves in CNS compartments, how viral persistence may be maintained in brain-associated cells, and what eradication strategies could work in the CNS without causing unacceptable neurotoxicity or inflammation. Projects that address the challenges of measuring and targeting HIV within CNS tissues and fluids are aligned with the intent of the program.
The FOA is open to a wide range of scientific approaches and settings, explicitly welcoming studies conducted in both domestic (U.S.) and international environments. It also signals strong interest in multidisciplinary science, encouraging (but not requiring) collaborative teams and alliances. This language typically supports applications that integrate expertise across fields such as virology, neuroimmunology, neurology, pharmacology, imaging, clinical HIV medicine, neuropathology, computational biology, and biomarker development. While collaboration is not mandatory, the FOA clearly frames CNS HIV persistence as a complex problem that can benefit from coordinated perspectives and shared resources.
Eligibility is broad and includes many types of applicant organizations. Standard eligible applicants listed include state, county, city or township governments; special district governments; independent school districts; public and state-controlled institutions of higher education; private institutions of higher education; federally recognized Native American tribal governments; public housing authorities/Indian housing authorities; Native American tribal organizations that are not federally recognized tribal governments; nonprofits with or without 501(c)(3) status (excluding institutions of higher education); for-profit organizations (other than small businesses); small businesses; and other organizations. The FOA additionally highlights categories often emphasized by NIH for inclusivity and capacity building, including Alaska Native and Native Hawaiian Serving Institutions, Asian American Native American Pacific Islander Serving Institutions (AANAPISIs), Hispanic-serving Institutions, Historically Black Colleges and Universities (HBCUs), Tribally Controlled Colleges and Universities (TCCUs), faith-based or community-based organizations, eligible federal agencies, U.S. territories or possessions, regional organizations, and non-domestic (non-U.S.) entities/foreign organizations. This breadth indicates NIH is seeking a diverse applicant pool and is open to proposals that leverage different institutional strengths, including community and international partners where appropriate.
From the administrative details provided, the funding instrument is an NIH research project grant (R01), falling under the health funding activity category, and tied to CFDA numbers 93.242, 93.853, 93.855, and 93.856. The FOA was created on 2016-12-13, and the original closing date listed is 2020-05-07. The listing does not provide an award ceiling or expected number of awards in the provided source data, so applicants would typically consult the full FOA text and NIH institute/center participation to understand budget expectations, project period norms, and whether any special review considerations apply.
Overall, this opportunity targets one of the hardest remaining barriers to an HIV cure: persistent virus in anatomically and immunologically distinct compartments of the body, with the CNS being a high-priority reservoir because of its clinical consequences and the complexity of safely delivering eradication strategies to the brain. The FOA is structured to support rigorous mechanistic studies as well as translational paths that could help move CNS-focused HIV cure research from concept to actionable interventions.Apply for PA 17 084
- The National Institutes of Health in the health sector is offering a public funding opportunity titled "Eradication of HIV-1 from Central Nervous system Reservoirs (R01)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.242, 93.853, 93.855, 93.856.
- This funding opportunity was created on 2016-12-13.
- Applicants must submit their applications by 2020-05-07. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- Eligible applicants include: State governments, County governments, City or township governments, Special district governments, Independent school districts, Public and State controlled institutions of higher education, Native American tribal governments (Federally recognized), Public housing authorities/Indian housing authorities, Native American tribal organizations (other than Federally recognized tribal governments), Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education, Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education, Private institutions of higher education, For-profit organizations other than small businesses, Small businesses, Others.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Frequently Asked Questions (FAQs)
What is the title and funding opportunity number for this grant?
The opportunity is titled "The Eradication of HIV-1 from Central Nervous System Reservoirs (R01)" and the Funding Opportunity Number (FOA) is PA-17-084.
What agency is offering this funding opportunity?
This is a National Institutes of Health (NIH) discretionary grant solicitation.
What type of grant mechanism is this?
The funding instrument is an NIH research project grant (R01).
What is the central purpose of this FOA?
The central purpose is to support research that explains why HIV-1 can persist in the central nervous system (CNS) even when a person is on effective antiretroviral therapy with viral suppression in the blood, and to develop, test, or refine strategies that could eradicate these CNS reservoirs or neutralize their clinical impact.
What problem is this FOA trying to address?
The FOA targets HIV-1 persistence in the CNS despite successful treatment as measured in peripheral blood. It recognizes that the CNS has unique biology, a distinct immune environment, and drug penetration constraints that can allow HIV-1 to persist in sanctuary-like conditions.
Why is the CNS a focus area for HIV-1 persistence research?
The CNS is considered a high-priority reservoir because it is anatomically and immunologically distinct, can be difficult for drugs to penetrate effectively, and is linked to clinical consequences. The FOA emphasizes the complexity of safely delivering eradication strategies to the brain.
What kinds of research does the FOA support (basic, translational, or both)?
The FOA supports both basic and translational research. This can range from fundamental lab-based discovery (for example, identifying relevant cell types and pathways involved in persistence) to research aimed at practical interventions, biomarkers, or therapeutic approaches relevant to patient care.
What types of studies are aligned with the intent of this program?
Studies aligned with the program include those that clarify biological mechanisms enabling HIV-1 persistence in CNS compartments, investigate how HIV behaves in CNS tissues and fluids, examine persistence in brain-associated cells, and develop eradication or mitigation strategies suitable for the CNS.
Does the FOA encourage research on how to measure or target HIV in the CNS?
Yes. Projects that address challenges in measuring and targeting HIV within CNS tissues and fluids are described as aligned with the intent of the program.
Are there safety concerns highlighted for CNS-focused eradication strategies?
Yes. The FOA notes the need for strategies that could work in the CNS without causing unacceptable neurotoxicity or inflammation.
Is this FOA limited to studies in the United States?
No. The FOA explicitly welcomes studies conducted in both domestic (U.S.) and international environments and includes eligibility for non-domestic (non-U.S.) entities/foreign organizations.
Is multidisciplinary research encouraged?
Yes. The FOA signals strong interest in multidisciplinary science and encourages (but does not require) collaborative teams and alliances.
What disciplines or areas of expertise are mentioned as relevant?
The FOA references integration across areas such as virology, neuroimmunology, neurology, pharmacology, imaging, clinical HIV medicine, neuropathology, computational biology, and biomarker development.
Are collaborations required to apply?
No. Collaboration is encouraged, but it is not mandatory.
Who is eligible to apply?
Eligibility is broad and includes many organization types, such as state/county/city or township governments, special district governments, independent school districts, public and state-controlled institutions of higher education, private institutions of higher education, federally recognized Native American tribal governments, public housing authorities/Indian housing authorities, Native American tribal organizations that are not federally recognized tribal governments, nonprofits with or without 501(c)(3) status (excluding institutions of higher education), for-profit organizations (other than small businesses), small businesses, and other organizations.
Does the FOA highlight any additional institution types for inclusivity or capacity building?
Yes. It highlights Alaska Native and Native Hawaiian Serving Institutions, Asian American Native American Pacific Islander Serving Institutions (AANAPISIs), Hispanic-serving Institutions, Historically Black Colleges and Universities (HBCUs), Tribally Controlled Colleges and Universities (TCCUs), faith-based or community-based organizations, eligible federal agencies, U.S. territories or possessions, regional organizations, and non-domestic (non-U.S.) entities/foreign organizations.
What is the funding activity category?
The opportunity is categorized under health.
What CFDA numbers are associated with this FOA?
The CFDA numbers listed are 93.242, 93.853, 93.855, and 93.856.
When was this FOA created?
The FOA was created on 2016-12-13.
What is the original closing date listed for this opportunity?
The original closing date listed in the provided information is 2020-05-07.
Does the provided information include an award ceiling or expected number of awards?
No. The provided source data does not include an award ceiling or an expected number of awards.
What should applicants do to understand budget expectations or project period norms?
Based on the provided information, applicants would typically consult the full FOA text and NIH institute/center participation to understand budget expectations, project period norms, and any special review considerations.
Browse more opportunities from the same category: Health
Next opportunity: Cancer Center Support Grants (CCSGs) for NCI-designated Cancer Centers (P30)
Previous opportunity: DRL FY16 Strengthening Local Independent Media in Belarus
Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for PA 17 084
Applicants also applied for:
Applicants who have applied for this opportunity (PA 17 084) also looked into and applied for these:
| Funding Opportunity |
|---|
| NIBIB Biomedical Technology Resource Centers (P41) Apply for PAR 17 083 Funding Number: PAR 17 083 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Request for Comment on USAID's Burma Planned Maternal, Neonatal, and Child Health-Health Systems Strengthening (MNCH-HSS) activity Apply for RFI 17 MNCH ACTIVITY BURMA Funding Number: RFI 17 MNCH ACTIVITY BURMA Agency: Burma USAID - Rangoon Category: Health Funding Amount: $30,000,000 |
| Exploratory Analyses of Existing Cohorts, Data Sets, and Stored Biospecimens to Address Clinical Aging Research Questions (R21) Apply for PA 17 089 Funding Number: PA 17 089 Agency: National Institutes of Health Category: Health Funding Amount: $200,000 |
| Secondary Analyses of Existing Cohorts, Data Sets and Stored Biospecimens to Address Clinical Aging Research Questions (R01) Apply for PA 17 088 Funding Number: PA 17 088 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Maximizing Investigators' Research Award (R35) Apply for PAR 17 094 Funding Number: PAR 17 094 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Planning for Non-Communicable Diseases and Disorders Research Training Programs in Low and Middle Income Countries (D71) Apply for PAR 17 097 Funding Number: PAR 17 097 Agency: National Institutes of Health Category: Health Funding Amount: $46,000 |
| NEI Translational Research Program (TRP) to Develop Novel Therapies and Devices for the Treatment of Visual System Disorders (R24) Apply for PAR 17 099 Funding Number: PAR 17 099 Agency: National Institutes of Health Category: Health Funding Amount: $1,500,000 |
| National Centers for Cryoelectron Microscopy (U24) Apply for RFA RM 17 002 Funding Number: RFA RM 17 002 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| NINDS Efficacy Clinical Trials (U01) Apply for PAR 17 102 Funding Number: PAR 17 102 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Strengthening the HIV Pre-Exposure Prophylaxis (PrEP) Care Continuum through Behavioral, Social, and Implementation Science (R21) Apply for PA 17 103 Funding Number: PA 17 103 Agency: National Institutes of Health Category: Health Funding Amount: $200,000 |
| Strengthening the HIV Pre-Exposure Prophylaxis (PrEP) Care Continuum through Behavioral, Social, and Implementation Science (R01) Apply for PA 17 104 Funding Number: PA 17 104 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Fc Receptor (FcR) and Antibody Effector Function in HIV Vaccine Discovery (R01) Apply for PA 17 113 Funding Number: PA 17 113 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| NK Cells to Induce Immunological Memory to Prevent HIV Infection (R01) Apply for PA 17 114 Funding Number: PA 17 114 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Development of Socially-Assistive Robots (SARs) to Engage Persons with Alzheimer's Disease (AD) and AD-Related Dementias (ADRD), and their Caregivers (R41/R42) Apply for PAR 17 107 Funding Number: PAR 17 107 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Development of Socially-Assistive Robots (SARs) to Engage Persons with Alzheimer's Disease (AD) and AD-Related Dementias (ADRD), and their Caregivers (R43/R44) Apply for PAR 17 108 Funding Number: PAR 17 108 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Targeted basic behavioral and social science and intervention development for HIV prevention and care (R01) Apply for PA 17 106 Funding Number: PA 17 106 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Targeted basic behavioral and social science and intervention development for HIV prevention and care (R21) Apply for PA 17 105 Funding Number: PA 17 105 Agency: National Institutes of Health Category: Health Funding Amount: $200,000 |
| NINDS Exploratory Clinical Trials (R01) Apply for PAR 17 122 Funding Number: PAR 17 122 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Project Manager for Kenya PEPFAR Sites Analysis Apply for SBUR SOGAC 16 003 Funding Number: SBUR SOGAC 16 003 Agency: Office of the Secretary Category: Health Funding Amount: $3,100,000 |
| Expanding and Strengthening Family Planning Service Options in Uganda Apply for RFA 617 17 000002 Funding Number: RFA 617 17 000002 Agency: Uganda USAID-Kampala Category: Health Funding Amount: $35,000,000 |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Inside Our Applicants Portal
Access Applicants Portal
- Grants Repository - Access current and historic funding opportunities with ease. Thousands of funding opportunities are published every week. We can help you sort through the database and find the eligible ones to apply for.
- Applicant Video Guides - The grant application process can be challenging to follow. We can help you with intuitive video guides to speed up the process and eliminate errors in submissions.
- Grant Proposal Wizard - We have developed a network of private funding organizations and investors across the United States. We can reach out and submit your proposal to these contacts to maximize your chances of getting the funding you need.
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Learn More
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "PA 17 084", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.
